Modulators of ATP-binding cassette transporters

24-12-2013 дата публикации

Номер:

US8614327B2

Автор: SHETH URVI, FANNING LEV T D, NUMA MEHDI MICHEL DJAMEL, BINCH HAYLEY, HURLEY DENNIS, ZHOU JINGLAN, HADIDA RUAH SARA S, HAZLEWOOD ANNA, SILINA ALINA, VAIRAGOUNDAR RAJENDRAN, VAN GOOR FREDRICK, GROOTENHUIS PETER D J, BOTFIELD MARTYN, FANNING LEV T. D., HADIDA RUAH SARA S., GROOTENHUIS PETER D. J.

Принадлежит: VERTEX PHARMA, VERTEX PHARMACEUTICALS INCORPORATED

Контакты:

Номер заявки: 69-13-20120924

Дата заявки: 30-11-2012

The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.

CPC - классификация

A A6 A61 A61P A61P1 A61P1/A61P1/1 A61P1/10 A61P1/16 A61P1/18 A61P11 A61P11/A61P11/0 A61P11/00 A61P11/02 A61P11/06 A61P15 A61P15/A61P15/0 A61P15/08 A61P19 A61P19/A61P19/0 A61P19/08 A61P19/1 A61P19/10 A61P2 A61P21 A61P21/A61P21/0 A61P21/04 A61P25 A61P25/A61P25/0 A61P25/00 A61P25/08 A61P25/1 A61P25/14 A61P25/16 A61P25/2 A61P25/28 A61P27 A61P27/A61P27/0 A61P27/02 A61P27/04 A61P3 A61P3/A61P3/0 A61P3/06 A61P3/1 A61P3/10 A61P35 A61P35/A61P35/0 A61P35/00 A61P37 A61P37/A61P37/0 A61P37/08 A61P5 A61P5/A61P5/0 A61P5/00 A61P5/1 A61P5/16 A61P5/18 A61P7 A61P7/A61P7/1 A61P7/12 A61P9 A61P9/A61P9/0 A61P9/00 C C0 C07 C07C C07C2 C07C21 C07C215 C07C215/C07C215/7 C07C215/76 C07D C07D2 C07D20 C07D209 C07D209/C07D209/0 C07D209/08 C07D209/1 C07D209/14 C07D209/18 C07D209/4 C07D209/42 C07D209/9 C07D209/94 C07D21 C07D213 C07D213/C07D213/2 C07D213/20 C07D213/7 C07D213/73 C07D215 C07D215/C07D215/2 C07D215/22 C07D215/227 C07D215/3 C07D215/38 C07D215/5 C07D215/56 C07D217 C07D217/C07D217/0 C07D217/06 C07D22 C07D223 C07D223/C07D223/1 C07D223/16 C07D26 C07D265 C07D265/C07D265/3 C07D265/36 C07D27 C07D279 C07D279/C07D279/1 C07D279/16 C07D3 C07D31 C07D311 C07D311/C07D311/5 C07D311/58 C07D4 C07D40 C07D401 C07D401/C07D401/1 C07D401/12 C07D401/14 C07D405 C07D405/C07D405/1 C07D405/12 C07D409 C07D409/C07D409/1 C07D409/12 C07D41 C07D413 C07D413/C07D413/1 C07D413/12 C07D417 C07D417/C07D417/1 C07D417/12 C07D47 C07D471 C07D471/C07D471/1 C07D471/10

IPC - классификация

A A6 A61 A61K A61K3 A61K31 A61K31/A61K31/0 A61K31/04 C C0 C07 C07D C07D2 C07D21 C07D215 C07D215/C07D215/3 C07D215/38

Цитирование НПИ

Brown, R.K., et al., "Derivatives of Indole, 6-Amino-3-indoleacetic Acid," JACS, 1955, vol. 77, No. 14, pp. 3839-3842.
Dhar, T.G. Murali, et al., "3-Cyanoindole-Based Inhibitors of Inosine Monophosphate Dehydrogenase: Synthesis and Initial Structure-Activity Relationships," Bioorg. Med. Chem. Lett., 2003, vol. 13, No. 20, pp. 3557-3560.
Grohe, Klaus, et al., "Synthese von 1-Amino-4-chinolon-3-carbonsauren," Liebigs Annalen Der Chemie, 1987, vol. 10, pp. 871-879.
Haynes, R.K., et al., "Amine Oxidation and the Chemistry of Quinone Imines. Part I. 3-Meth-oxy-4-t-butylaniline," J. Chem. Soc, Perkins Trans., 1972, vol. 1, pp. 396-408.
Heilbron, Isidor M., et al., "The Intermolecular Condensation of Acetylmethylanthranilic Acid by Means of Phosphorus Pentachioride and the Formation of a Complex isoCyanine Dye," J. Chem. Soc., 1928, pp. 934-941.
Hennequin, Laurent F., et al., "Design and Structure-Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors," J. Med. Chem., 1999, vol. 42, No. 26, pp. 5369-5389.
Hester, J.B., et al., "Enzyme Inhibitory Activity of 3-(2-Aminobutyl)indole Derivatives," J. Med. Chem., 1964, vol. 7, No. 3, pp. 274-279.
Imanishi, T., et al., "Evidene that a Hybrid Molecule of Norfloxacin and Biphenylacetic Acid is a Potent Antagonist at the GABAa Receptor," Neuropharmacology, 1996, vol. 35, No. 9/10, pp. 1271-1277.
International Search Report for PCT/US2005/022768, dated Jul. 10, 2006.
International Search Report for PCT/US2010/059920, dated Jan. 27, 2011.
Irie, Kazuhiro, et al., "Synthesis of 6-Substituted Indolactams by Microbial Conversion," Tetrahedron, 1995, vol. 51, No. 22, pp. 6255-6266.
Ito, Y., et al., "Inhibition of GABAa Receptor Chloride Channel by Quinolones and Norfloxacin-Biphenylacetic Acid Hybrid Compounds," Neuropharmacology, 1996, vol. 35, No. 9/10, pp. 1263-1269.
Kaminsky, Daniel, et al., "Quinolone Antibacterial Agents. Oxolinic Acid and Related Compounds," J. Med. Chem., 1968, vol. 11, No. 1, pp. 160-163.
Kurata, Hitoshi, et al., "A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives," Bioorg. Med. Chem. Lett., 2004, vol. 14, pp. 1183-1186.
Ma, Tonghui, et al., "High-affinity Activators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Chloride Conductance Identified by High-throughput Screening," J. Biol. Chem., 2002, vol. 277, No. 40, pp. 27235-37241.
Nosova, E.V., et al., "Synthesis of New Fluorinated Derivatives of Quinolinecarboxylic Acids," Chem. of Heter. Compounds, 2002, vol. 38, No. 8, pp. 922-928.
Perez-Guille, B., et al., "Pharmacokinetics of a cephalone (CQ-M-EPCA) in rats after oral, intraduodenal and intravenous administration," International J. of Pharm., 2004, vol. 282, No. 1-2, pp. 87-94.
Showalter, H.D. Hollis, et al., "Concise Syntheses of the Novel 1H-Pyrrolo[3,2-g]quinazoline Ring System and its [2,3-f] Angular Isomer," J. Org. Chem., 1996, vol. 61, No. 3, pp. 1155-1158.
Srivastava, Sanjay K., et al., "Quinolones: Novel Probes in Antifilarial Chemotheraphy," J. Med. Chem., 2000, vol. 43, No. 11, pp. 2275-2279.
Van Es, T., et al., "1-Alkyl-1,4-dihydro-4-iminoquinoline-3-carboxylic acids: Synthesis, Structure and Properties," S. Afr. J. Chem., 2002, vol. 55, pp. 13-33.
Van Es, Theodorus, et al., "N,1-Dialky1-7-(alkylamino)-4-(alkylimino)-a,4-dihydroquinoline-3-carboxamides and Their 4-Oxo Derivatives: Synthesis and Properties," S. Afr. J. Chem., 2001, vol. 54, pp. 102-117.

Получить PDF